参考文献/References:
[1] SINGER M, DEUTSCHMAN C S, SEYMOUR C W,et al. The third international consensus definitions forsepsis and septic shock (sepsis-3)[J]. the Journal of theAmerican Medical Association, 2016, 315(8): 801-810.
[2] XIE Jianfeng，WANG Hongliang，KANG Yan，et al.The epidemiology of sepsis in Chinese ICUs: a nationalcross-sectional survey[J]. Critical Care Medicine, 2020,48(3) : e209-e218.
[3] DICKSON K, LEHMANN C. Inflammatory responseto different toxins in experimental sepsis models[J].International Journal of Molecular Sciences, 2019,20(18): 4341.
[4] 梅毅, 胡选义, 杨思远. 激活素A 的调控作用[J]. 医学综述, 2019, 25(5):856-861.MEI Yi, HU Xuanyi, YANG Siyuan. Regulationfunction of activin-A[J].Medical Recapitulate，2019,25(5):856-861.
[5] 姜晓月，张文静，查才军，等．C 反应蛋白单体在炎症- 血栓网络中作用的研究进展[J]. 国际免疫学杂志, 2021, 44(3):351-354．JIANG Xiaoyue，ZHANG Wenjing，CHA Caijun，et al.Progress of monomeric C-reactive protein in theinflammatory-thrombotic network[J]．InternationalJournal of Immunology, 2021,43(3):351-354.
[6] JIN Juan, GONG Jianguang, ZHAO Li, et al. Inhibitionof high mobility group box 1 (HMGB1) attenuatespodocyte apoptosis and epithelial-mesenchymaltransition by regulating autophagy flux[J]. Journal ofDiabetes, 2019, 11(10): 826-836.
[7] RANDI A M, SMITH K E, CASTAMAN G.von willebrand factor regulation of blood vesselformation[J]. Blood, 2018, 132(2): 132-140.
[8] 中国医师协会急诊医师分会，中国研究型医院学会休克与脓毒症专业委员会. 中国脓毒症/ 脓毒性休克急诊治疗指南(2018)[J]. 感染·炎症·修复，2019,20(1): 3-22.Emergency Physicans Branch of Chinese MedicalDoctor Assiciation , Shock and Sepsis ProfessionalCommittee of Chinese Research Hospital Association.Guidelines for emergency treatment of sepsis/septicshock in China (2018) [J]. Infection InflammationRepair, 2019, 20(1): 3-22.
[9] RELLO J, VALENZUELA-S?NCHEZ F, RUIZRODRIGUEZM, et al. Sepsis: a review of advancesin management[J]. Advances in Therapy, 2017, 34(11):2393-2411.
[10] CHAKER A M, ZISSLER U M, POULOS N, et al.Activin-A is a pro-inflammatory regulator in type-2-driven upper airway disease[J]. International Archivesof Allergy and Immunology, 2018, 176(1): 15-25.
[11] ZHANG Xuejun, LI Yang, TAI Guixiang, et al. Effectsof activin A on the activities of the mouse peritonealmacrophages[J]. Cellular & Molecular Immunology,2005, 2(1): 63-67.
[12] UELAND T, AUKRUST P, AAKHUS S, et al. Activina and cardiovascular disease in type 2 diabetesmellitus[J]. Diabetes & Vascular Disease Research,2012, 9(3): 234-237.
[13] LEE J K, CHOI S M, LEE J, et al. Serum activin-Aas a predictive and prognostic marker in critically illpatients with sepsis[J]. Respirology (Carlton, Vic.),2016, 21(5): 891-897.
[14] YAO Zhenyu, ZHANG Yanmin, WU Haibin.Regulation of C-reactive protein conformation ininflammation[J]. Inflammation Research, 2019, 68(10) :815-823.
[15] MOUTACHAKKIR M, LAMRANI HANCHI A,BARAOU A, et al. Immunoanalytical characteristicsof C-reactive protein and high sensitivity C-reactiveprotein[J]. Annales de Biologie Clinique, 2017, 75(2):225-229.
[16] 袁鼎山, 李爱林.PCT, IL-6 及CRP 对脓毒症的诊断价值[J]. 中国现代医学杂志, 2018, 28(32): 86-90.YUAN Dingshan , LI Ailin. Value of PCT, IL-6 andCRP in diagnosis of sepsis[J]. China Journal of ModernMedicine, 2018, 28(32): 86-90.
[17] 张静娇，邓春青．与疾病相关的HMGB1 基因多态性研究进展[J]．国际生物医学工程杂志, 2019,42(4): 357-361.ZHANG Jingjiao,DENG Chunqing. Research progressof HMGB1 gene polymorphism related to disease [J].International Journal of Biomedical Engineering, 2019,42(4): 357-361.
[18] DENG Meihong, TANG Yiting, LI Wenbo, et al. Theendotoxin delivery protein HMGB1 mediates caspase-11-Dependent lethality in sepsis[J]. Immunity, 2018,49(4): 740-753,e3.
[19] 安曙光, 覃炳军, 卢广轩, 等. 脓毒症患者血清高迁移率族蛋白B1 对调节性T 细胞免疫功能的影响[J].实用医学杂志, 2018, 34(17): 2912-2915.AN Shuguang,QIN Bingjun,LU Guangxuan, et al.Effect of high mobility group protein B1 on theimmune function of regulatory T cells [J]. The Journalof Practical Medicine, 2018, 34(17): 2912-2915.
[20] REN Chao, TONG Yalin, LI Juncong, et al. Earlyantagonism of cerebral high mobility group box-1protein is benefit for sepsis induced brain injury[J].Oncotarget, 2017, 8(54): 92578-92588.
[21] ZHAO Jingjing, WU Shengdi, SUN Tianle, et al. Highmobility group box 1: an immune-regulatory protein[J].Current Gene Therapy, 2019, 19(2): 100-109.
[22] KR?GER-GENGE A, BLOCKI A, FRANKE R P,et al. Vascular endothelial cell biology: an update[J].International Journal of Molecular Sciences, 2019,20(18): 4411.
[23] LANCELLOTTI S, SACCO M, BASSO M, et al.Mechanochemistry of von willebrand factor[J].Biomolecular Concepts, 2019, 10(1): 194-208.
[24] PEETERMANS M, MEYERS S, LIESENBORGHS L,et al. Von willebrand factor and ADAMTS13 impact onthe outcome of staphylococcus aureus sepsis[J]. Journalof Thrombosis and Haemostasis, 2020, 18(3): 722-731.
[25] RIETVELD I M, LIJFERING W M, CESSIE S, etal. High levels of coagulation factors and venousthrombosis risk: strongest association for factor VIIIand von Willebrand factor[J]. Journal of Thrombosisand Haemostasis, 2019, 17(1): 99-109.
相似文献/References:
[1]沈丽娟a,孙 杰a,吴 晓b,等.老年脓毒症患者血清清蛋白水平与其危重程度及预后的相关性[J].现代检验医学杂志,2017,32(01):131.[doi:10.3969/j.issn.1671-7414.2017.01.036]
SHEN Li-juana,SUN Jiea,WU Xiaob,et al.Relationship of Albumin Levels with the Prognosis
and Severity of Illness among Elderly Sepsis Patients[J].Journal of Modern Laboratory Medicine,2017,32(01):131.[doi:10.3969/j.issn.1671-7414.2017.01.036]
[2]佟 丽,黄丽萍,石晓霞,等.血栓弹力图检测新型冠状病毒肺炎患者凝血功能的探讨分析[J].现代检验医学杂志,2020,35(04):97.[doi:10.3969/j.issn.1671-7414.2020.04.024]
TONG Li,HUANG Li-ping,SHI Xiao-xia,et al.Investigation and Analysis of Thromboelastography in the Detection of COVID-19 Patients[J].Journal of Modern Laboratory Medicine,2020,35(01):97.[doi:10.3969/j.issn.1671-7414.2020.04.024]
[3]肖武强,徐敏丹,吴先正.脓毒症患者血清肠型脂肪酸结合蛋白、二胺氧化酶水平检测对早期肠组织损伤及预后的评估价值[J].现代检验医学杂志,2021,36(01):10.[doi:10.3969/j.issn.1671-7414.2021.01.003]
XIAO Wu-qiang,XU Min-dan,WU Xian-zheng.Evaluation Value of Serum Intestinal Fatty Acid Binding Protein and Diamine Oxidase in the Early Stage of Intestinal Tissue Injury and Prognosis in Patients with Sepsis[J].Journal of Modern Laboratory Medicine,2021,36(01):10.[doi:10.3969/j.issn.1671-7414.2021.01.003]
[4]张 晨,孙虹佳.新型感染标志物在脓毒症早期诊断中的应用及研究进展[J].现代检验医学杂志,2021,36(01):156.[doi:10.3969/j.issn.1671-7414.2021.01.038]
ZHANG Chen,SUN Hong-jia.Latest Research Progress of Early Serum Inflammatory and Oxidative Stress Mediator of Sepsis[J].Journal of Modern Laboratory Medicine,2021,36(01):156.[doi:10.3969/j.issn.1671-7414.2021.01.038]
[5]张 珍,王新庄.脓毒症患者血清 YKL-40 水平检测与急性肾损伤早期诊断的相关性研究[J].现代检验医学杂志,2021,36(03):148.[doi:10.3969/j.issn.1671-7414.2021.03.034]
ZHANG Zhen,WANG Xin-zhuang.Correlation between Serum YKL-40 Level and Early Diagnosis of AcuteKidney Injury in Patients with Sepsis[J].Journal of Modern Laboratory Medicine,2021,36(01):148.[doi:10.3969/j.issn.1671-7414.2021.03.034]
[6]王 海,肖 华,陈兴壮.血浆miR-223-3p，PCT，IL-6和CRP水平联合检测对脓毒症实验诊断及预后的价值研究[J].现代检验医学杂志,2021,36(05):51.[doi:10.3969/j.issn.1671-7414.2021.05.011]
WANG Hai,XIAO Hua,CHEN Xing-zhuang.Value of Combined Detection of Plasma miR-223-3p, PCT, IL-6 and CRPLevels in Experimental Diagnosis and Prognosis of Sepsis[J].Journal of Modern Laboratory Medicine,2021,36(01):51.[doi:10.3969/j.issn.1671-7414.2021.05.011]
[7]洪 莉,郑 青,陈永香,等.脓毒症并发急性肾损伤患儿血清miR-452-3p的水平表达及其临床意义[J].现代检验医学杂志,2021,36(06):176.[doi:10.3969/j.issn.1671-7414.2021.06.038]
HONG Li,ZHENG Qing,CHEN Yong-xiang,et al.Expression and Clinical Significance of Serum miR-452-3p in Children with Sepsis Complicated with Acute Kidney Injury[J].Journal of Modern Laboratory Medicine,2021,36(01):176.[doi:10.3969/j.issn.1671-7414.2021.06.038]
[8]胡 伟,张 涛,盛尚春,等.IGF-1R通过调控JAK/STAT信号通路对脓毒症大鼠作用机制的研究[J].现代检验医学杂志,2022,37(02):6.[doi:10.3969/j.issn.1671-7414.2022.02.002]
HU Wei,ZHANG Tao,SHENG Shang-chun,et al.Mechanism of IGF-1R on Sepsis Rats by Regulating JAK / STAT Signaling Pathway[J].Journal of Modern Laboratory Medicine,2022,37(01):6.[doi:10.3969/j.issn.1671-7414.2022.02.002]
[9]于大勇a,卢 新b,任平香b,等.老年脓毒症患者血清循环Netrin-1表达水平对发生脑损伤风险的预测价值研究[J].现代检验医学杂志,2022,37(02):76.[doi:10.3969/j.issn.1671-7414.2022.02.016]
YU Da-yonga,LU Xinb,REN Ping-xiangb,et al.Study on the Value of Serum Circulating Netrin-1 Expression Level in Predicting the Risk of Brain Injury in Elderly Patients with Sepsis[J].Journal of Modern Laboratory Medicine,2022,37(01):76.[doi:10.3969/j.issn.1671-7414.2022.02.016]
[10]邓颖云,邱成英,吴日暖,等.脓毒症患儿血浆miR-455-5p和miR-483-5p检测的临床应用[J].现代检验医学杂志,2022,37(03):79.[doi:10.3969/j.issn.1671-7414.2022.03.016]
DENG Ying-yun,QIU Cheng-ying,WU Ri-nuan,et al.Clinical Application of Plasma miR-455-5p and miR-483-5p in Children with Sepsis[J].Journal of Modern Laboratory Medicine,2022,37(01):79.[doi:10.3969/j.issn.1671-7414.2022.03.016]